![Paulette A. Dillon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paulette A. Dillon was the founder of Atreca, Inc. (founded in 2010) where she held the title of Senior Vice President-Corporate Development.
Ms. Dillon is also the founder of Nuon Therapeutics, Inc. Ms. Dillon's former jobs include Principal at Syntex Corp., Vice President-Marketing & Business Development at Exelixis, Inc., Chief Business Officer & Senior Vice President at Avidia, Inc., Vice President at Hoffmann-La Roche, Inc., Chief Business Officer at Celera Group, Chief Business Officer & Senior Vice President at Anacor Pharmaceuticals LLC, and VP-Strategic Market & Business Development at Roche Corp.
Ms. Dillon received an undergraduate degree from the University of California, Los Angeles.
| Sociétés | Poste | Fin |
|---|---|---|
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Corporate Officer/Principal | - |
Syntex Corp.
 Syntex Corp. Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Corporate Officer/Principal | - |
| EXELIXIS, INC. | Sales & Marketing | - |
| ATRECA, INC. | Fondateur | - |
Roche Corp. | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 10 |
|---|---|
Syntex Corp.
Syntex Corp. Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Health Technology |
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
Avidia, Inc.
 Avidia, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Atreca, Inc.
 Atreca, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel antibody-based immune therapeutics to treat a range of solid tumor cancers | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Health Technology |
Celera Group
 Celera Group Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics for cancer, autoimmune and inflammatory diseases | Health Technology |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Anacor Pharmaceuticals LLC
 Anacor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a bio pharmaceutical company | Health Technology |
Nuon Therapeutics, Inc.
 Nuon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat inflammation and neurological diseases | Health Technology |
Roche Corp. |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
